WT1 and neoplasm: The presence of clonally expanded WT1126-specific CTLs with advanced differentiation stages in the PB of solid tumor patients prior to WT1 peptide vaccine therapy suggests that these CTLs may rapidly trigger tumor attack after WT1 peptide vaccine administration.